Eyam Vaccines and Immunotherapeutics is at the forefront of developing next-generation platforms for vaccines and nanomedicine, specifically through their innovative technologies, the Jennerator and Gemini. The Jennerator leverages artificial intelligence and machine learning to design vaccines and therapeutics tailored for various viruses and cancer tumors. By utilizing proprietary algorithms, it analyzes extensive datasets to identify optimal epitope targets, ensuring the creation of effective therapies. Meanwhile, the Gemini platform enhances the delivery of these therapeutic payloads, boasting a highly stable structure that can endure multiple freeze/thaw cycles while remaining functional after lyophilization. This combination of advanced design and delivery systems positions Eyam to respond rapidly to pandemic threats and customize solutions as needed.

In addition to their core platforms, Eyam employs smart vectors that can function as either self-amplifying RNA or DNA, significantly increasing the payload capacity compared to first-generation vectors. This allows for the accommodation of larger therapeutic payloads, enhancing the potential for effective immune responses. The integration of the Jennerator and Gemini systems creates a cost-effective, AI-driven production process for vaccines and immunotherapeutics, aimed at delivering safer and more potent solutions. Eyam's commitment to innovation in biotechnology is evident in their mission to revolutionize healthcare by providing on-demand, highly effective therapies that address both local and global health challenges.

Canada

At Eyam, our mission is to bring “Next Generation” vaccine and therapeutic technologies to market to solve today's health care needs.

Cancer

Immune System Diseases

Infectious Diseases

Lymphatic Diseases

Eyam Vaccines and Immunotherapeutics

COVID-19

Influenza

mRNA vaccines ( Gemini platform)

Biologics

Vaccines

mRNA vaccine ( Gemini platform)

Leukemia

Lymphoma

Antibody biologics

Antibodies

Artificial Intelligence

NanoMedicine/Nanotechnology

Contract Manufacturing

Contract Research

Therapeutic

Eyam Vaccines and Immunotherapeutics

Company Details